ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therapeutics for CNS disorders.
AVXL | US
Overview
Corporate Details
- ISIN(s):
- US0327973006
- LEI:
- Country:
- United States of America
- Address:
- 630 5TH AVENUE, 10111 NEW YORK
- Website:
- https://www.anavex.com
- Sector:
- Manufacturing
Description
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for central nervous system (CNS) disorders. The company develops targeted drug candidates for neurodegenerative and neurodevelopmental diseases, including Alzheimer's disease, Parkinson's disease, and Rett syndrome. Anavex's approach is centered on precision medicine, utilizing small molecule drugs designed to restore cellular homeostasis. Its lead investigational compound, blarcamesine (ANAVEX®2-73), is an orally available sigma-1 receptor (S1R) agonist being evaluated for its potential to treat a range of neurological conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ANAVEX LIFE SCIENCES CORP. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANAVEX LIFE SCIENCES CORP.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANAVEX LIFE SCIENCES CORP. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
